GSK plc Comprehensive Income Attributable To Noncontrolling Interests
GSK plc (GLAXF) reported Comprehensive Income Attributable To Noncontrolling Interests of GBP 555.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2026-03-06
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-12-31 | 555.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 372.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 355.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 637.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 691.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 605.00M GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 548.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 422.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 488.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 753.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | -42.00M GBP 20-F/A · filed 2018-03-20 |